Marcus price target raised to $25 from $22 at Benchmark

Benchmark raised the firm’s price target on Marcus (MCS) to $25 from $22 and keeps a Buy rating on the shares. After having recently concluded a non-deal roadshow with the executive team, the firm believes the company’s theatrical segment is poised to be a key area of growth in the coming years, the analyst tells investors.